The Belfer Institute for Applied Cancer Science at Dana-Farber Cancer Institute and Evotec AG today announced a research collaboration aimed at discovering and commercialising novel cancer treatments based on epigenetic drug mechanisms. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/dana-farbers-belfer-institute-for-applied-cancer-science-and-evotec-establish-collaboration-in-oncology-5131
Evotec expands compound management capability to East Coast of the United States
Evotec AG today announced that Evotec (US) Inc. has executed a multi-year lease on a facility specifically designed to expand the offering of its Compound Management Services on the East Coast of the United States. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-expands-compound-management-capability-to-east-coast-of-the-united-states-5129
New hormone to treat diabetes published in 'Cell'
Evotec AG today announced an auspicious step in research from Harvard University. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/new-hormone-to-treat-diabetes-published-in-cell-5127
Evotec extends drug discovery alliance with Genentech
Evotec AG today announced that it has extended its drug discovery alliance with Genentech, a member of the Roche Group, for three additional years. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-extends-drug-discovery-alliance-with-genentech-5125
Forward step by step with Action Plan 2016 – Continued revenue growth – Significant pipeline progress
Evotec AG today reported financial results and corporate updates for the fiscal year ended 31 December 2012. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/forward-step-by-step-with-action-plan-2016—continued-revenue-growth—significant-pipeline-progress-5123
Corporate Update
Evotec AG today announced that Dr Werner Lanthaler, Chief Executive Officer of Evotec, will resume his role as Chief Executive Officer of the Company with immediate effect after a period of leave due to health reasons. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/corporate-update-5119
Evotec achieves milestone in drug discovery collaboration with Ono Pharmaceutical Co., Ltd.
Evotec AG today announced that a compound identified and optimised in a research collaboration with Ono Pharmaceutical Co., Ltd. has been nominated to enter pre-clinical development, leading to the payment of an agreed milestone. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-achieves-milestone-in-drug-discovery-collaboration-with-ono-pharmaceutical-co-ltd-5117
Evotec and Yale University form Open Innovation Alliance
Evotec AG today announced that it has entered into a strategic partnership with Yale University. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-yale-university-form-open-innovation-alliance-5115
Evotec expands collaboration with MedImmune, receives milestone payment
Evotec AG today announced that it has expanded the scope of its collaboration with MedImmune, the global biologics arm of AstraZeneca, after hitting a key milestone. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-expands-collaboration-with-medimmune-receives-milestone-payment-5111
Evotec acquires Cell Culture Service GmbH
Evotec AG today announced the acquisition of all shares in Cell Culture Service GmbH, a Hamburg-based company which supports the cell culture needs of a world-wide customer base of biotech and Pharmaceutical companies. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-acquires-cell-culture-service-gmbh-5109